Trial
NCT01134835
PPAR-gamma: a Novel Therapeutic Target for Asthma?
Phase IVTERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Nottingham
Collaborators
—
Condition
Asthma
Intervention
placebo
Why stopped
safety concerns with pioglitazone
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-12-03